Tag: NSCLC therapy
-
FDA Approves First Generics of Gilotrif (afatinib) Tablets – What This Means for Patients
The FDA has officially approved the first generic versions of Gilotrif (afatinib) tablets, a targeted lung cancer treatment used for specific types of non-small cell lung cancer (NSCLC). This update matters because generics typically lower costs, expand access, and give patients more treatment options. The approval covers the same uses as the brand-name drug, meaning…